Biotech News

Pulse Biosciences to Host Analyst Event on April 25, 2026

Pulse Biosciences (PLSE)Pulse Biosciences2026-04-17 11:00 ESTCompany update

Management to discuss late-breaking data and the clinical program for its nPulse Cardiac Catheter System HAYWARD, Calif. --(BUSINESS WIRE)--Apr. 17, 2026-- Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy,

Pulse Biosciences

Nanosecond Pulsed-Field Ablation Pulse Biosciences develops the nPulse platform, which delivers proprietary nanosecond pulsed-field energy to ablate targeted tissue. The technology is designed to create nonthermal cellular effects and is being evaluated in cardiac and soft-tissue applications. Cardiac Catheter System The nPulse Cardiac...

Recent company news

PLSEPulse Biosciences2026-08-18 11:00 EST

Stock data

Close: 50.42 USD
Market cap: 1.68B USD
Exchange: NASDAQ
Sector: Biopharma
Location: United States

Pulse Biosciences to Host Analyst Event on April 25, 2026

Related news

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results

Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call

Delcath Systems to Host Second Quarter 2026 Earnings Call

Pulse Biosciences

Recent company news

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results

Pulse Biosciences to Present at Canaccord Genuity’s 46th Annual Growth Conference

Pulse Biosciences Surpasses Enrollment Midpoint in NANOPULSE-AF IDE Pivotal Study

Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026

Stock data